Clinical Trials for Dasatinib (BMS-354825)

2 Open Trials

Trial TypeProtocol No. &
Open Date
Summary
TreatmentVICCGI1173
07/31/2012
A Phase 1 Study of Gemcitabine, Dasatinib and Erlotinib in Patients with Advanced Pancreatic Carcinoma
TreatmentVICCPED1186
06/11/2012
CA180-372 / AALL1122 - A Phase 2 Multi-Center, Historically-Controlled Study of Dasatinib (IND# 66, 971) Added to Standard Chemotherapy in Pediatric Patients with Newly Diagnosed Philadelphia Chromosome Positive (Ph+) Acute Lymphoblastic Leukemia (ALL)

Back to Find By Drug

You do not have JavaScript enabled. This site works better with JavaScript turned on.